Prospective observational study to investigate the predictive factors on the efficacy of molecular targeting therapy for unresectable advanced hepatocellular carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2015
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 13 Feb 2013 New trial record